| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 39 |
| 1 | METHOTREXATE | 26 |
| 2 | METHOTREXATE SODIUM | 26 |
| 3 | ASPIRIN | 23 |
| 4 | ASPIRIN 325 MG | 23 |
| 5 | ASPIRIN 81 MG | 23 |
| 6 | METHYLPREDNISOLONE | 21 |
| 7 | CYCLOSPORINE | 19 |
| 8 | INFLIXIMAB | 18 |
| 9 | PREDNISOLONE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM THIOSULFATE | 6 | 0.0107 |
| 1 | BARICITINIB | 17 | 0.0056 |
| 2 | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 1 | 0.0018 |
| 3 | TRIMETHOBENZAMIDE HYDROCHLORIDE | 2 | 0.0014 |
| 4 | TOFACITINIB CITRATE | 18 | 0.0013 |
| 5 | METHYLNALTREXONE BROMIDE | 2 | 0.0013 |
| 6 | MANNITOL | 6 | 0.0012 |
| 7 | ANAKINRA | 17 | 0.0010 |
| 8 | NALOXEGOL OXALATE | 3 | 0.0008 |
| 9 | ELOSULFASE ALFA | 4 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 1 | Osmotic Diuretic [EPC] | 6 | 0.0011 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 17 | 0.0010 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 4 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 5 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Anticholinergic [EPC] | 6 | 0.0004 |
| 8 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 9 | Plasma Volume Expander [EPC] | 1 | 0.0003 |